John David Finley

CIK: 0001851034

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (14.3%)

Position reduction

Option Exercises (M)4 (28.6%)

Derivative conversions

Awards (A)5 (35.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (21.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PALI

PALISADE BIO, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

PALI
PALISADE BIO, INC.
Oct 6, 2026
Exercise(M)
Direct
3.2M shares-
PALI
PALISADE BIO, INC.
Oct 6, 2026
Tax Payment(F)
Direct
1.4M shares at avg. $1.49$2.1M
PALI
PALISADE BIO, INC.
Aug 19, 2026
Gift(G)
Indirect
88.4K shares-
PALI
PALISADE BIO, INC.
Aug 19, 2026
Gift(G)
Direct
88.4K shares-
PALI
PALISADE BIO, INC.
Jul 7, 2026
Exercise(M)
Direct
133 shares at avg. $0.70$93.1
PALI
PALISADE BIO, INC.
Jul 7, 2026
Sale(S)
Direct
146.8K shares at avg. $2.07$303K
PALI
PALISADE BIO, INC.
Jul 6, 2026
Exercise(M)
Direct
335.2K shares-
PALI
PALISADE BIO, INC.
Feb 12, 2026
Sale(S)
Direct
3.9K shares at avg. $1.75$7K
PALI
PALISADE BIO, INC.
Feb 11, 2026
Exercise(M)
Direct
13.3K shares-
PALI
PALISADE BIO, INC.
Feb 9, 2026
Award(A)
Restricted Stock Units
Direct
2M shares-
PALI
PALISADE BIO, INC.
Oct 6, 2025
Award(A)
Restricted Stock Units
Direct
9.2M shares-
PALI
PALISADE BIO, INC.
Sep 4, 2025
Award(A)
Phantom Units
Direct
323.4K shares-
PALI
PALISADE BIO, INC.
Feb 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
47K shares-
PALI
PALISADE BIO, INC.
Feb 11, 2025
Award(A)
Restricted Stock Units
Direct
40K shares-

		Type	Shares	Price		Ownership
Oct 6, 2026	PALI PALISADE BIO, INC.	Exercise(M)	3,227,384	-	$0	Direct
Oct 6, 2026	PALI PALISADE BIO, INC.	Tax Payment(F)	1,411,982	$1.49	$2,103,853	Direct
Aug 19, 2026	PALI PALISADE BIO, INC.	Gift(G)	88,400	-	$0	Indirect
Aug 19, 2026	PALI PALISADE BIO, INC.	Gift(G)	88,400	-	$0	Direct
Jul 7, 2026	PALI PALISADE BIO, INC.	Exercise(M)	133	$0.70	$93	Direct
Jul 7, 2026	PALI PALISADE BIO, INC.	Sale(S)	146,798	$2.07	$303,343	Direct
Jul 6, 2026	PALI PALISADE BIO, INC.	Exercise(M)	335,167	-	$0	Direct
Feb 12, 2026	PALI PALISADE BIO, INC.	Sale(S)	3,896	$1.75	$6,818	Direct
Feb 11, 2026	PALI PALISADE BIO, INC.	Exercise(M)	13,333	-	$0	Direct
Feb 9, 2026	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	2,011,000	-	-	Direct
Oct 6, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	9,179,400	-	-	Direct
Sep 4, 2025	PALI PALISADE BIO, INC.	Award(A) Phantom Units	323,400	-	-	Direct
Feb 11, 2025	PALI PALISADE BIO, INC.	Award(A) Stock Option (Right to Buy)	47,000	-	-	Direct
Feb 11, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	40,000	-	-	Direct

1-14 of 14 transactions

About Finley John David

Finley John David (SEC CIK 0001851034) files insider reports with the SEC as CEO CFO of PALISADE BIO, INC. (PALI).

Signal8 holds 8 ownership filings by Finley John David, all Form 4s, filed between Feb 13, 2025 and Oct 7, 2026. Those filings report 14 transactions, from Feb 11, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Finley John David's filings is in DENVER, CO.

Recent filings by Finley John David

Oct 6, 2026: Option exercise of PALI shares (Form 4, code M).
Oct 6, 2026: Tax withholding of PALI shares (Form 4, code F).
Aug 19, 2026: Gifts of PALI shares (2 lines, Form 4, code G).
Jul 7, 2026: Option exercise of PALI shares (Form 4, code M).
Jul 7, 2026: Open-market sale of PALI shares (Form 4, code S).

Other insiders filing for PALISADE BIO, INC. (PALI)

How to read Form 4 transaction codes